Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
BJU International|April 29, 2017
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomyRobert A Huddart, Alison Birtle, Lauren Maynard, et al.
Biochemical Pharmacology|October 5, 2010
DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditionsGrant D Stewart, Jyoti Nanda, Elad Katz, et al.
Physics and Imaging in Radiation Oncology|November 17, 2022
Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics featuresThomas Berger, David J Noble, Leila E A Shelley, et al.
Acta Oncologica (Stockholm, Sweden)|February 21, 2023
Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patientsThomas Berger, David J Noble, Zhuolin Yang, et al.
Physics and Imaging in Radiation Oncology|January 20, 2023
Assessing the generalisability of radiomics features previously identified as predictive of radiation-induced sticky saliva and xerostomiaThomas Berger, David J Noble, Zhuolin Yang, et al.
Nuclear Medicine Communications|October 15, 2025
UK real-world data of radium-223 dichloride in metastatic prostate cancerManreet Randhawa, Gail Buchanan, Irene M Stratton, et al.
BMJ Open|January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidanceShaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.
European Urology|October 8, 2024
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled TrialRobert Huddart, Shaista Hafeez, Clare Griffin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 24, 2023
Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER TrialR Huddart, S Hafeez, A Omar, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|May 5, 2015
Translational research will fail without surgical leadership: SCOTRRCC a successful surgeon-led Nationwide translational research infrastructure in renal cancerGrant D Stewart, Antony C P Riddick, Frances Rae, et al.
Pageof 7